ArticleOpen life sciences2025
Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity.
Article in Open life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HE4 is overexpressed in malignant lesions, and elevated serum HE4 levels have been applied as a biomarker for gynecologic cancers. While previous studies have demonstrated the HE4 activities in cancer biology, its role(s) in benign disease is unclear. In current study, we characterize the keratopathy phenotype of transgenic mice with HE4 overexpression (HE4-OE). HE4-OE mice started to display signs of keratitis such as eye-scratching, conjunctiva inflammation, red eyes, periocular secretions, and rough skin/hair loss around the eyes at 3 months after birth. All the mice suffered keratitis, severe corneal opacity and ELISA results indicated HE4 overexpression, and significantly increased IL-6 and TNF-α levels in the cornea. Immunostaining demonstrated the accumulation of disorganized collagen fibers, fibroblast activation, and the presence of vessel-like structures, indicating the progression of corneal opacification. The cornea alkali burn model showed increased HE4 expression, which was accompanied by the elevation of IL-6 and TNF-α in the cornea. Thus, both the HE4-OE and alkali burn models have correlated increased HE4 expression to inflammatory responses. These studies indicate that HE4 may play a significant role(s) in keratopathy and other physiopathological conditions of the eye.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.